Latest filings (excl ownership)
10-Q
2024 Q1
Quarterly report
29 Apr 24
8-K
Medifast Announces First Quarter 2024 Financial Results
29 Apr 24
DEFA14A
Additional proxy soliciting materials
26 Apr 24
DEF 14A
Definitive proxy
26 Apr 24
8-K
Medifast Announces Fourth Quarter and Full Year 2023 Financial Results
20 Feb 24
10-K
2023 FY
Annual report
20 Feb 24
8-K
Other Events
13 Dec 23
10-Q
2023 Q3
Quarterly report
6 Nov 23
8-K
Medifast Announces Third Quarter 2023 Financial Results
6 Nov 23
8-K
Regulation FD Disclosure
27 Sep 23
8-K
Medifast Announces Quarterly Dividend
7 Sep 23
8-K
Medifast Announces Second Quarter 2023 Financial Results
7 Aug 23
10-Q
2023 Q2
Quarterly report
7 Aug 23
8-K
Medifast Announces Quarterly Dividend
15 Jun 23
8-K
Medifast Enhances “Fuel for the Future” Program to Position the Business for Long-term Sustainable Growth
1 Jun 23
10-Q
2023 Q1
Quarterly report
1 May 23
8-K
Medifast Announces First Quarter 2023
1 May 23
DEF 14A
Definitive proxy
1 May 23
DEFA14A
Additional proxy soliciting materials
1 May 23
ARS
2022 FY
Annual report to shareholders
1 May 23
8-K
Departure of Directors or Certain Officers
20 Apr 23
8-K
Medifast Announces Quarterly Dividend
16 Mar 23
10-K
2022 FY
Annual report
21 Feb 23
8-K
Medifast Announces Fourth Quarter and Full Year 2022
21 Feb 23
8-K
Medifast Announces Quarterly Dividend
8 Dec 22
10-Q
2022 Q3
Quarterly report
3 Nov 22
8-K
Medifast Announces Third Quarter 2022 Financial Results
3 Nov 22
8-K
Medifast Announces Quarterly Dividend
8 Sep 22
10-Q
2022 Q2
Quarterly report
3 Aug 22
8-K
Medifast Announces Second Quarter 2022 Financial Results and Second Quarter 2022 Highlights Compared to the Prior-Year Period
3 Aug 22
8-K
Medifast, Inc. Announces Quarterly Dividend
16 Jun 22
8-K
Entry into a Material Definitive Agreement
3 Jun 22
8-K
Medifast, Inc. Announces $100M Accelerated Share Repurchase Program
1 Jun 22
10-Q
2022 Q1
Quarterly report
2 May 22
8-K
Medifast, Inc. Announces First Quarter 2022 Financial Results
2 May 22
DEFA14A
Additional proxy soliciting materials
21 Apr 22
DEF 14A
Definitive proxy
21 Apr 22
8-K
Medifast, Inc. Announces Quarterly Dividend
17 Mar 22
10-K
2021 FY
Annual report
23 Feb 22
8-K
Medifast, Inc. Announces Fourth Quarter and Full Year 2021 Financial Results
23 Feb 22
Latest ownership filings
4
James P. Maloney
19 Mar 24
4
Jonathan Barrett MacKenzie
19 Mar 24
4
Daniel R Chard
19 Mar 24
4
James P. Maloney
15 Mar 24
4
Jonathan Barrett MacKenzie
15 Mar 24
4
Daniel R Chard
15 Mar 24
4
SCOTT SCHLACKMAN
12 Mar 24
144
Notice of proposed sale of securities
8 Mar 24
4
Daniel R Chard
16 Feb 24
4
James P. Maloney
16 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
SC 13G/A
RENAISSANCE TECHNOLOGIES LLC
13 Feb 24
SC 13G/A
BlackRock Inc.
22 Jan 24
4
Andrea B Thomas
9 Nov 23
4
Michael A. Hoer
9 Nov 23
4
SCOTT SCHLACKMAN
9 Nov 23
4
JEFFREY J BROWN
9 Nov 23
4
Ming Xian
9 Nov 23
4
CONSTANCE J. HALLQUIST
30 Oct 23
4
Jonathan Barrett MacKenzie
15 Sep 23
4
JEFFREY J BROWN
16 Aug 23
144
Notice of proposed sale of securities
14 Aug 23
4
JEFFREY J BROWN
10 Aug 23
4
SCOTT SCHLACKMAN
10 Aug 23
4
Andrea B Thomas
10 Aug 23
4
Ming Xian
10 Aug 23
4
Michael A. Hoer
10 Aug 23
4
James P. Maloney
24 Jul 23
4
Ming Xian
20 Jun 23
4
SCOTT SCHLACKMAN
20 Jun 23
4
Michael A. Hoer
20 Jun 23
3
Elizabeth A. Geary
20 Jun 23
4
Andrea B Thomas
20 Jun 23
4
Elizabeth A. Geary
20 Jun 23
4
JEFFREY J BROWN
20 Jun 23
4
JEFFREY J BROWN
11 May 23
4
Michael A. Hoer
11 May 23
4
CONSTANCE J. HALLQUIST
11 May 23
4
Andrea B Thomas
11 May 23
4
SCOTT SCHLACKMAN
11 May 23